The government in Ontario, Canada, has approved the coverage of verteporfin [`Visudyne']

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 363, 2002 , pp. 12-12(1)

Publisher: Adis International

Keywords: Healthcare-expenditure; Healthcare-news; Macular-degeneration, treatment; Reimbursement; Verteporfin, therapeutic use

Language: English

Document Type: Short communication

Publication date: 2002-01-01

• In this: publication
• By this: publisher
• In this Subject: Pharmacology

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers